These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8981210)
1. L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6. Lou H; Kodama T; Wang YN; Katz N; Ramwell P; Foegh ML J Heart Lung Transplant; 1996 Dec; 15(12):1248-57. PubMed ID: 8981210 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Lou H; Kodama T; Zhao YJ; Maurice P; Wang YN; Katz N; Foegh ML Circulation; 1996 Dec; 94(12):3355-61. PubMed ID: 8989151 [TBL] [Abstract][Full Text] [Related]
19. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction. Voisine P; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Li J; Malik T; Rosinberg A; Sellke FW J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1414-20. PubMed ID: 15942586 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]